U.S. markets closed
  • S&P Futures

    3,962.50
    +0.50 (+0.01%)
     
  • Dow Futures

    33,868.00
    +11.00 (+0.03%)
     
  • Nasdaq Futures

    11,521.50
    -3.25 (-0.03%)
     
  • Russell 2000 Futures

    1,838.90
    +1.10 (+0.06%)
     
  • Crude Oil

    78.76
    +0.56 (+0.72%)
     
  • Gold

    1,763.70
    0.00 (0.00%)
     
  • Silver

    21.42
    -0.02 (-0.07%)
     
  • EUR/USD

    1.0343
    +0.0009 (+0.08%)
     
  • 10-Yr Bond

    3.7480
    +0.0450 (+1.22%)
     
  • Vix

    21.89
    -0.32 (-1.44%)
     
  • GBP/USD

    1.1974
    +0.0024 (+0.20%)
     
  • USD/JPY

    138.6060
    -0.0280 (-0.02%)
     
  • BTC-USD

    16,854.16
    +673.82 (+4.16%)
     
  • CMC Crypto 200

    400.98
    +12.26 (+3.15%)
     
  • FTSE 100

    7,512.00
    +37.98 (+0.51%)
     
  • Nikkei 225

    27,892.19
    -135.65 (-0.48%)
     

Why Atara Biotherapeutics Stock Is Crashing Today

Why Atara Biotherapeutics Stock Is Crashing Today

Shares of the next-generation cell therapy company Atara Biotherapeutics (NASDAQ: ATRA) are getting hammered today. Prior to Wednesday's opening bell, Atara announced that the closely watched multiple sclerosis candidate, known as ATA188, will continue its ongoing phase 2 trial without any changes. While this clinical update isn't necessarily bad news, some investors were clearly hoping that this interim status check would provide definitive proof that the therapy was on the right track.